<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 45 subjects after a cerebrovascular attack (age less than 55 years) and their first degree relatives -45 siblings, 60 children, 9 parents and 31 partners--<z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) levels by the ELISA method as well as some other <z:chebi fb="23" ids="18059">lipids</z:chebi>, <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> and <z:chebi fb="0" ids="13850">apoproteins</z:chebi> were assessed and compared with two control groups (I and II) of healthy subjects with a negative family history of early <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) levels were significantly higher not only in probands, as compared with the control group I (27.4 +/- 30.7 x 16.0 +/- 18.9; p &lt; 0.05, Mann Whitney U-test) but also in their children when compared with control group II (28.1 +/- 31.9 x 12.5 +/- 16.3; p &lt; 0.05) </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) levels did not correlate with age, there was, however, a significant positive correlation with total cholesterol (r = 0.2244, p &lt; 0.01), <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> (r = 0.2834, p &lt; 0.0001) and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (r = 0.1759, p &lt; 0.05) when Spearman's correlation coefficient was used </plain></SENT>
<SENT sid="3" pm="."><plain>Familial <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> Lp (a) defined as <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) higher than 25 mg/dl (or 30 mg/dl resp.) at least in two close relatives in one family was found in 27% (and 21.6%) evaluated families (10/37 and 8/37 resp.). "Risk" levels of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) &gt; 25-30 mg/dl were found most frequently in combination with other types of <z:e sem="disease" ids="C0020476" disease_type="Disease or Syndrome" abbrv="">hyperlipoproteinaemia</z:e>--in subjects with types IIa and IIb, in families in combination with <z:e sem="disease" ids="C0020474,C1704417" disease_type="Disease or Syndrome" abbrv="">familial combined hyperlipidaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results indicate that "risk" levels of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) are a frequent genetically conditioned <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> in patients with premature ischaemic cerebrovascular attacks </plain></SENT>
</text></document>